What is Western scientific medicine for depression?

What is Western scientific medicine for depression?

St John’s Wort is another example of a CAM/TM that is used to manage depression in New Zealand. The underlying philosophy of St John’s Wort is that an extract from the plant hypericum perforatum contains hypoformin which is the ‘drug’ that makes St John’s Wort effective for treating depression (5).

Which is an advantage of medication treatment for depression?

Antidepressants work by balancing chemicals in your brain called neurotransmitters that affect mood and emotions. These depression medicines can help improve your mood, help you sleep better, and increase your appetite and concentration.

What do doctors normally prescribe for depression?

Selective serotonin reuptake inhibitors (SSRIs) were launched in the mid to late 1980s. This generation of antidepressants is now the most common class used for depression. Examples include citalopram (Celexa), escitalopram (Lexapro), paroxetine (Paxil, Pexeva), fluoxetine (Prozac, Sarafem), and sertraline (Zoloft).

What is the best treatment for clinical depression?


  • Antidepressants are medicines that treat the symptoms of depression.
  • If a GP thinks you’d benefit from taking an antidepressant, you’ll usually be prescribed a modern type called a selective serotonin reuptake inhibitor (SSRI).

Which is the most effective treatment for depression?

Antidepressants are a common treatment, but there may be better and safer options for most patients. How Effective Are Drug Treatments for Depression? When patients are diagnosed with depression, the first treatment their doctor suggests is often antidepressant medication. Antidepressants have been a go-to therapy for decades.

How are drugs and psychotherapy used to treat depression?

1. Klerman GL, DiMascio A, Weissman M, et al. Treatment of depression by drugs and psychotherapy. Am J Psychiatry. 1974;131:186-191. 2. Luborsky L, Singer B, Luborsky L. Comparative studies of psychotherapies.

Do you need to take antidepressants for depression?

To be clear, this is not to say antidepressants have no place in the treatment of depression. More severe cases clearly benefit from medical therapy. Patients in “crisis” who may be contemplating harming themselves or others should seek immediate help, which often includes medication.

Which is better for severe depression, medication or placebo?

A study in the Journal of the American Medical Association supports his claim. It concludes that, while medications are substantially better than a placebo for patients with very severe depression, those benefits “may be minimal or nonexistent, on average, in patients with mild or moderate symptoms.”

The two most common treatments for clinical depression in Western medicine are psychotherapy and medications. A therapist provides counseling (talk therapy) and a family healthcare provider or psychiatrist provides medicine (such as SSRIs, selective serotonin reuptake inhibitors). These treatments can be very effective.

How does pharmacologic treatment relate to psychotherapy for depression?

In this model, pharmacologic treatment is aimed primarily at supporting the capacity of the patient to usefully engage in psychotherapy. The therapist then feels a direct connection to the medications and sees problems with medication (eg, noncompliance, fear of dependency, a tendency to develop side effects) as targets for therapeutic exploration.

Can a person take antidepressants for mild depression?

Some people doubt their usefulness, while others consider them to be essential. As is the case for many other treatments, these medications can help in some situations, but not in others. Antidepressants are effective for moderate, severe and chronic depression, but probably not for mild cases.

Which is better for depression single modality or combined treatment?

While combined treatment has been shown to be generally more effective than single-modality treatments and substantially more effective for certain kinds of patients, there is still much work that needs to be done to establish whether there are other subpopulations of patients with depression who would benefit from combined treatment.